Joneborg, Ulrika Bergamini, Alice Wallin, Emelie Mangili, Giorgia Solheim, Olesya Marquina, Gloria Casado, Antonio Rokkones, Erik Coulter, John Lok, Christianne A R
...
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
To evaluate outcomes of European cross-border multidisciplinary tumor boards in terms of participation, adherence to treatment recommendations, and access to novel treatment strategies. The European reference network for rare gynecological tumors (EURACAN G2 domain) aims to improve the diagnosis, management, and treatment of patients with these can...
Trozzi, Rita Rosati, Andrea Panico, Camilla Perisiano, Carlo Santoro, Angela Fagotti, Anna
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Gil-Ibanez, Blanca Tejerizo-Garcia, Alvaro Oliver, M Reyes Madariaga, Ainhoa Maiz Jimenez, Maria Gil Garcia, Alejandra Lopez-Gonzalez, Gregorio
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Advances in the treatment of gynecological cancers have led to increased survival in patients with gynecological cancers. Nevertheless, patients may still experience prevalent long term consequences, including lower limb lymphedema, depression, anxiety, sexual dysfunction, malnutrition, and sarcopenia, that negatively impact their quality of life. ...
Bizzarri, Nicolò Russo, Luca Dolciami, Miriam Zormpas-Petridis, Konstantinos Boldrini, Luca Querleu, Denis Ferrandina, Gabriella Pedone Anchora, Luigi Gui, Benedetta Sala, Evis
...
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Radiomics is the process of extracting quantitative features from radiological images, and represents a relatively new field in gynecological cancers. Cervical cancer has been the most studied gynecological tumor for what concerns radiomics analysis. The aim of this study was to report on the clinical applications of radiomics combined and/or compa...
Veiga, Nadia Muruzábal, Juan Carlos Aguirre, Sara Lapeña, Sonia Tarrio, Orencio Vicaría, Iván
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Chen, Yu Zheng, Ying Chen, Sijing Peng, Shiyi
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Holloway, Robert W Thaker, Premal Mendivil, Alberto A Ahmad, Sarfraz Al-Niaimi, Ahmed N Barter, James Beck, Tiffany Chambers, Setsuko K Coleman, Robert L Crafton, Sarah M
...
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Treatment options for patients with platinum-resistant/refractory ovarian cancers are limited and only marginally effective. The development of novel, more effective therapies addresses a critical unmet medical need. Olvimulogene nanivacirepvec (Olvi-Vec), with its strong immune modulating effect on the tumor microenvironment, may provide re-sensit...
Capozzi, Vito Andrea Rotondella, Isabella De Finis, Alessandra Scarpelli, Elisa Ghi, Tullio Berretta, Roberto
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Nasser, Sara Togo, Pierre Adegne Elghanmi, Adil Bilir, Esra Sehouli, Jalid
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Bartl, Thomas Alberts, Anita Papadopoulos, Sofia-Christina Wolf, Andrea Muellauer, Leonhard Hofstetter, Gerda Grimm, Christoph Cacsire Castillo-Tong, Dan
Published in
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
The prognosis of patients with advanced stage mucinous epithelial ovarian cancer remains poor due to a modest response to platinum-based chemotherapy and the absence of therapeutic alternatives. As targeted approaches may help to overcome these limitations, the present study evaluates biomarkers indicative of potential immune-checkpoint inhibitor t...